000			01380 a2200373 4500
005			20250513155346.0
264		0	_c19981229
008			199812s 0 0 eng d
022			_a0090-4295
024	7		_a10.1016/s0090-4295(98)00424-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aOrnstein, D K
245	0	0	_aBiochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed. _h[electronic resource]
260			_bUrology _cDec 1998
300			_a1094-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAndrogen Antagonists _xtherapeutic use
650	0	4	_aFinasteride _xtherapeutic use
650	0	4	_aFlutamide _xtherapeutic use
650	0	4	_aGonadotropin-Releasing Hormone _xanalogs & derivatives
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrchiectomy
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatic Neoplasms _xblood
650	0	4	_aTreatment Failure
700	1		_aSmith, D S
700	1		_aAndriole, G L
773	0		_tUrology _gvol. 52 _gno. 6 _gp. 1094-7
856	4	0	_uhttps://doi.org/10.1016/s0090-4295(98)00424-5 _zAvailable from publisher's website
999			_c9800573 _d9800573